Stelara 90 mg

STELARA 90 MG is a subcutaneous solution containing ustekinumab, used for managing moderate to severe plaque psoriasis and other immune-mediated conditions. This biologic therapy is designed to target specific proteins in the immune system.

STELARA 90 MG is primarily used for the treatment of moderate to severe plaque psoriasis, a chronic skin condition characterized by red, itchy, and scaly patches. It may also be prescribed for other immune-mediated conditions, such as psoriatic arthritis, where the body's immune system attacks healthy cells. The active ingredient, ustekinumab, works by blocking specific proteins that contribute to inflammation and skin cell overproduction.

Common effects of STELARA 90 MG may include reactions at the injection site, such as redness, itching, or swelling. Some individuals might experience headaches, fatigue, or upper respiratory infections. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a healthcare provider.

STELARA 90 MG should be handled with care, ensuring proper storage and administration as directed. It is important to inform healthcare providers about any allergies or medical conditions before starting treatment. Regular monitoring may be required to assess the body's response to the medication.

STELARA 90 MG may interact with other medications, including those that suppress the immune system. It is advisable to consult a healthcare provider before combining it with other treatments. Alcohol and certain foods may also affect how the body responds to this medication.